Cargando…
Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis
BACKGROUND: Despite reported antiproliferative activity of vitamin A and its common use for cancer, there is no comprehensive synthesis of its safety and efficacy in lung cancers. To address this issue we conducted a systematic review of the safety and efficacy of vitamin A for the treatment and pre...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124481/ https://www.ncbi.nlm.nih.gov/pubmed/21738614 http://dx.doi.org/10.1371/journal.pone.0021107 |
_version_ | 1782207096826101760 |
---|---|
author | Fritz, Heidi Kennedy, Deborah Fergusson, Dean Fernandes, Rochelle Doucette, Steve Cooley, Kieran Seely, Andrew Sagar, Stephen Wong, Raimond Seely, Dugald |
author_facet | Fritz, Heidi Kennedy, Deborah Fergusson, Dean Fernandes, Rochelle Doucette, Steve Cooley, Kieran Seely, Andrew Sagar, Stephen Wong, Raimond Seely, Dugald |
author_sort | Fritz, Heidi |
collection | PubMed |
description | BACKGROUND: Despite reported antiproliferative activity of vitamin A and its common use for cancer, there is no comprehensive synthesis of its safety and efficacy in lung cancers. To address this issue we conducted a systematic review of the safety and efficacy of vitamin A for the treatment and prevention of lung cancers. METHODS AND FINDINGS: Two independent reviewers searched six electronic databases from inception to July 2009 for clinical, observational, and preclinical evidence pertaining to the safety and efficacy of vitamin A and related retinoids for lung cancers. 248 studies were included for full review and analysis. Five RCTs assessed treatment of lung cancers, three assessed primary prevention, and three looked at secondary prevention of lung cancers. Five surrogate studies, 26 phase I/II, 32 observational, and 67 preclinical studies were also included. 107 studies were included for interactions between vitamin A and chemo- or radiation- therapy. Although some studies demonstrated benefits, there was insufficient evidence overall to support the use of vitamin A or related retinoids for the treatment or prevention of lung cancers. Retinyl palmitate combined with beta carotene increased risk of lung cancer in smokers in the large CARET trial. Pooling of three studies pertaining to treatment and three studies on secondary prevention revealed no significant effects on response rate, second primary tumor, recurrence, 5-year survival, and mortality. There was a small improvement in event free survival associated with vitamin A compared to controls, RR 1.24 (95% CI 1.13–1.35). The synthetic rexinoid bexarotene increased survival significantly among a subset of patients in two RCTs (p<0.014, <0.087). CONCLUSIONS: There is a lack of evidence to support the use of naturally occuring retinoids for the treatment and prevention of lung cancers. The rexinoid bexarotene may hold promise for use among a subset of patients, and deserves further study. |
format | Online Article Text |
id | pubmed-3124481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-31244812011-07-07 Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis Fritz, Heidi Kennedy, Deborah Fergusson, Dean Fernandes, Rochelle Doucette, Steve Cooley, Kieran Seely, Andrew Sagar, Stephen Wong, Raimond Seely, Dugald PLoS One Research Article BACKGROUND: Despite reported antiproliferative activity of vitamin A and its common use for cancer, there is no comprehensive synthesis of its safety and efficacy in lung cancers. To address this issue we conducted a systematic review of the safety and efficacy of vitamin A for the treatment and prevention of lung cancers. METHODS AND FINDINGS: Two independent reviewers searched six electronic databases from inception to July 2009 for clinical, observational, and preclinical evidence pertaining to the safety and efficacy of vitamin A and related retinoids for lung cancers. 248 studies were included for full review and analysis. Five RCTs assessed treatment of lung cancers, three assessed primary prevention, and three looked at secondary prevention of lung cancers. Five surrogate studies, 26 phase I/II, 32 observational, and 67 preclinical studies were also included. 107 studies were included for interactions between vitamin A and chemo- or radiation- therapy. Although some studies demonstrated benefits, there was insufficient evidence overall to support the use of vitamin A or related retinoids for the treatment or prevention of lung cancers. Retinyl palmitate combined with beta carotene increased risk of lung cancer in smokers in the large CARET trial. Pooling of three studies pertaining to treatment and three studies on secondary prevention revealed no significant effects on response rate, second primary tumor, recurrence, 5-year survival, and mortality. There was a small improvement in event free survival associated with vitamin A compared to controls, RR 1.24 (95% CI 1.13–1.35). The synthetic rexinoid bexarotene increased survival significantly among a subset of patients in two RCTs (p<0.014, <0.087). CONCLUSIONS: There is a lack of evidence to support the use of naturally occuring retinoids for the treatment and prevention of lung cancers. The rexinoid bexarotene may hold promise for use among a subset of patients, and deserves further study. Public Library of Science 2011-06-27 /pmc/articles/PMC3124481/ /pubmed/21738614 http://dx.doi.org/10.1371/journal.pone.0021107 Text en Fritz et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Fritz, Heidi Kennedy, Deborah Fergusson, Dean Fernandes, Rochelle Doucette, Steve Cooley, Kieran Seely, Andrew Sagar, Stephen Wong, Raimond Seely, Dugald Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis |
title | Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis |
title_full | Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis |
title_fullStr | Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis |
title_full_unstemmed | Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis |
title_short | Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis |
title_sort | vitamin a and retinoid derivatives for lung cancer: a systematic review and meta analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124481/ https://www.ncbi.nlm.nih.gov/pubmed/21738614 http://dx.doi.org/10.1371/journal.pone.0021107 |
work_keys_str_mv | AT fritzheidi vitaminaandretinoidderivativesforlungcancerasystematicreviewandmetaanalysis AT kennedydeborah vitaminaandretinoidderivativesforlungcancerasystematicreviewandmetaanalysis AT fergussondean vitaminaandretinoidderivativesforlungcancerasystematicreviewandmetaanalysis AT fernandesrochelle vitaminaandretinoidderivativesforlungcancerasystematicreviewandmetaanalysis AT doucettesteve vitaminaandretinoidderivativesforlungcancerasystematicreviewandmetaanalysis AT cooleykieran vitaminaandretinoidderivativesforlungcancerasystematicreviewandmetaanalysis AT seelyandrew vitaminaandretinoidderivativesforlungcancerasystematicreviewandmetaanalysis AT sagarstephen vitaminaandretinoidderivativesforlungcancerasystematicreviewandmetaanalysis AT wongraimond vitaminaandretinoidderivativesforlungcancerasystematicreviewandmetaanalysis AT seelydugald vitaminaandretinoidderivativesforlungcancerasystematicreviewandmetaanalysis |